Maintaining patents protecting biologics or small-molecule drugs
| Autor: | Srivatsan Raghunathan, Sangita Kumari, Gayatri Saberwal, Muthukrishnakumar Kandasamy, Ganesan Marimuthu |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Biological Products
Drug Industry United States Food and Drug Administration Biomedical Engineering Bioengineering Computational biology Pharmacology Legislation Drug Applied Microbiology and Biotechnology Small molecule United States Patents as Topic Pharmaceutical Preparations Humans Molecular Medicine Business health care economics and organizations Biotechnology |
| Zdroj: | Nature Biotechnology. 30:50-53 |
| ISSN: | 1546-1696 1087-0156 |
| DOI: | 10.1038/nbt.2082 |
| Popis: | A look at the maintenance rates of US patents protecting FDA-approved biologics and small molecules. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|